Hormonal treatments for adenomyosis

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 22, Issue 2, 2008, Pages 333-339

  Fedele, Luigi ^a   Bianchi, Stefano ^a   Frontino, Giada ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

adenomyosis; levonorgestrel IUD; medical therapy; menorrhagia; pelvic pain

Indexed keywords

AROMATASE INHIBITOR; DANAZOL; ESTROGEN RECEPTOR; GONADORELIN AGONIST; LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT;

ADENOMYOSIS; AMENORRHEA; BONE DENSITY; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG EFFICACY; DRUG RECEPTOR BINDING; DRUG WITHDRAWAL; DYSMENORRHEA; ENDOMETRIOSIS; ENZYME INHIBITION; ESTROGEN DEFICIENCY; ESTROGEN SYNTHESIS; HORMONAL THERAPY; HOT FLUSH; HUMAN; HYSTERECTOMY; INTRAUTERINE CONTRACEPTIVE DEVICE; MENORRHAGIA; MENTAL INSTABILITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; TRANSVAGINAL ECHOGRAPHY; UTERUS MYOMA; VAGINAL DRYNESS;

DANAZOL; ENDOMETRIOSIS; ESTROGEN ANTAGONISTS; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; INTRAUTERINE DEVICES; LEVONORGESTREL;

EID: 39749083972     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2007.07.006     Document Type: Review

References (39)

1. Ferenczy A. Pathophysiology of adenomyosis. Hum Reprod Update 4 (1998) 312-322
2. Bergeron C., Amant F., and Ferenczy A. Pathology and physiopathology of adenomyosis. Best Pract Res Clin Obstet Gynaecol 20 (2006) 511-521
3. Vercellini P., Vigano P., Somigliana E., et al. Adenomyosis: epidemiological factors. Best Pract Res Clin Obstet Gynaecol 20 (2006) 465-477
4. Matalliotakis I.M., Kourtis A.I., and Panidis D.K. Adenomyosis. Obstet Gynecol Clin North Am 30 (2003) 63-82
5. Sanberg E.G., and Cohn F. Adenomyosis in the gravid uterus at term. Am J Obstet Gynecol 84 (1962) 1457-1465
6. Zaloudek C., and Norris H.J. Mesenchymal tumors of the uterus. In: Kurman R.J. (Ed). Blaustein's Pathology of the Female Genital Tract. 3rd edn. (1987), Springer Verlag, New York 374-528
7. Hendrickson M.R., and Kempson R.L. Non-neoplastic conditions of the myometrium and uterine serosa. In: Fox H. (Ed). Obstetrical and Gynaecological Pathology. 3rd edn. (1987), Churchill Livingstone, London 405-407
8. Levgur M., Abadi M.A., and Tucker A. Adenomyosis: symptoms, histology, and pregnancy terminations. Obstet Gynecol 95 (2000) 688-691
9. Sammour A., Pirwany I., Usubutun A., et al. Correlations between extent and spread of adenomyosis and clinical symptoms. Gynecol Obstet Invest 54 (2002) 213-216
10. Kunz G., Beil D., Huppert P., et al. Structural abnormalities of the uterine wall in women with endometriosis and infertility visualized by vaginal sonography and magnetic resonance imaging. Hum Reprod 15 (2000) 76-82
11. Kunz G., Beil D., Huppert P., et al. Adenomyosis in endometriosis: prevalence and impact on fertility. Evidence from magnetic resonance imaging. Hum Reprod 20 (2005) 2309-2316
12. Fedele L., Bianchi S., Dorta M., et al. Transvaginal ultrasonography in the diagnosis of diffuse adenomyosis. Fertil Steril 58 (1992) 94-97
13. Uduwela A.S., Perera M.A., Aiqing L., et al. Endometrial-myometrial interface: relationship to adenomyosis and changes in pregnancy. Obstet Gynecol Surv 55 (2000) 390-400
14. Arnold L.L., Ascher S.M., Schruefer J.J., et al. The nonsurgical diagnosis of adenomyosis. Obstet Gynecol 86 (1995) 461-465
15. Ascher S.M., Jha R.C., and Reinhold C. Benign myometrial conditions: leiomyomas and adenomyosis. Top Magn Reson Imaging 14 (2003) 281-304
16. Brosens J.J., de Souza N.M., Barker F.G., et al. Endovaginal ultrasonography in the diagnosis of adenomyosis uteri: identifying the predictive characteristics. Br J Obstet Gynaecol 102 (1995) 471-474
17. Rabinovici J., and Stewart E.A. New interventional techniques for adenomyosis. Best Pract Res Clin Obstet Gynaecol 20 (2006) 617-636
18. Tamaya T., Motoyama T., Ohono Y., et al. Steroid receptor levels and histology of endometriosis and adenomyosis. Fertil Steril 31 (1979) 396-400
19. Ueki K., Kumagai K., Yamashita H., et al. Expression of apoptosis-related proteins in adenomyotic uteri treated with danazol and GnRH agonists. Int J Gynecol Pathol 23 (2004) 248-258
20. Urabe M., Yamamoto T., Kitawaki J., et al. Estrogen biosynthesis in human uterine adenomyosis. Acta Endocrinol (Copenh) 121 (1989) 259-264
21. Yamamoto T., Noguchi T., Tamura T., et al. Evidence for estrogen synthesis in adenomyotic tissues. Am J Obstet Gynecol 169 (1993) 734-738
22. Ezaki K., Motoyama H., and Sasaki H. Immunohistologic localization of estrone sulfatase in uterine endometrium and adenomyosis. Obstet Gynecol 98 (2001) 815-819
23. Otsuki Y., Misaki O., Sugimoto O., et al. Cyclic bcl-2 gene expression in human uterine endometrium during menstrual cycle. Lancet 344 (1994) 28-29
24. Grow D.R., and Filer R.B. Treatment of adenomyosis with long-term GnRH analogues: a case report. Obstet Gynecol 78 (1991) 538-539
25. Nelson J.R., and Corson S.L. Long-term management of adenomyosis with a gonadotropin-releasing hormone agonist: a case report. Fertil Steril 59 (1993) 441-443
26. Huang F.J., Kung F.T., Chang S.Y., et al. Effects of short-course buserelin therapy on adenomyosis. A report of two cases. J Reprod Med 44 (1999) 741-744
27. Hirata J.D., Moghissi K.S., and Ginsburg K.A. Pregnancy after medical therapy of adenomyosis with a gonadotropin-releasing hormone agonist. Fertil Steril 59 (1993) 444-445
28. Silva P.D., Perkins H.E., and Schauberger C.W. Live birth after treatment of severe adenomyosis with a gonadotropin-releasing hormone agonist. Fertil Steril 61 (1994) 171-172
29. Lin J., Sun C., and Zheng H. Gonadotropin-releasing hormone agonists and laparoscopy in the treatment of adenomyosis with infertility. Chin Med J (Engl) 113 (2000) 442-445
30. Huang W.-S., Ynag T.-S., and Yuan C.-C. Successful pregnancy after treatment of deep adenomyosis with cytoreductive surgery and subsequent gonadotropin-releasing hormone agonist: a case report. Chin Med J (Engl) 61 (1998) 726-729
31. Edelman A.B., Gallo M.F., Jensen J.T., et al. Continuous or extended cycle vs. cyclic use of combined oral contraceptives for contraception. Cochrane Database Syst Rev 20 (2005) CD004695
32. Critchley H.O., Wang H., Jones R.L., et al. Morphological and functional features of endometrial decidualization following long-term intrauterine levonorgestrel delivery. Hum Reprod 13 (1998) 1218-1224
33. Varma R., Sinha D., and Gupta K. Non-contraceptive uses of levonorgestrel-releasing hormone system (Lng-IUS). A systematic enquiry and overview. Eur J Obstet Gynecol Reprod Biol 125 (2006) 9-28
34. Fedele L., Bianchi S., Raffaelli R., et al. Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device. Fertil Steril 68 (1997) 426-429
35. Fong Y.F., and Singh K. Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system. Contraception 60 (1999) 173-175
36. He S.M., Wei M.X., Han Y.H., et al. Effect of levonorgestrel-releasing intrauterine system in the treatment of adenomyosis. Zhonghua Fu Chan Ke Za Zhi 40 (2005) 536-538
37. Maia Jr. H., Maltez A., Coelho G., et al. Insertion of Mirena after endometrial resection in patients with adenomyosis. J Am Assoc Gynecol Laparosc 10 (2003) 512-516
38. Igarashi M., Abe Y., Fukuda M., et al. Novel conservative medical therapy for uterine adenomyosis with a danazol-loaded intrauterine device. Fertil Steril 74 (2000) 412-413
39. Farquhar C., and Brosens I. Medical and surgical management of adenomyosis. Best Pract Res Clin Obstet Gynaecol 20 (2006) 603-616